Compass Therapeutics
Clinical trials sponsored by Compass Therapeutics, explained in plain language.
-
New drug CTX-8371 tested in patients with advanced cancers
Disease control Recruiting nowThis early-stage study tests a new drug called CTX-8371 in people with advanced cancers that have not responded to standard treatments. The main goal is to check the drug's safety and find the best dose. About 85 adults with certain types of lung, breast, lymphoma, head and neck,…
Phase: PHASE1 • Sponsor: Compass Therapeutics • Aim: Disease control
Last updated May 26, 2026 08:19 UTC
-
New drug CTX-10726 tested in patients with advanced cancers
Disease control Recruiting nowThis study is testing a new drug called CTX-10726 in people with advanced cancers (stomach, liver, endometrial, or kidney) that have not responded to standard treatments. The main goal is to check the drug's safety and find the best dose. About 70 participants will receive the dr…
Phase: PHASE1 • Sponsor: Compass Therapeutics • Aim: Disease control
Last updated May 22, 2026 13:50 UTC